Emily’s Entourage’s Gene-based Therapy Initiative

The objective of this initiative is to fund promising therapies and drug-delivery mechanisms that have the potential to accelerate the development of gene-based therapies for people with CF.

Potential areas of interest include but are not limited to the following list.

• Gene Editing
• Exogenous Delivery of Full-length CFTR Gene
• RNA Editing
• Non-viral vectors for DNA and RNA delivery

Funding: $100, 000 per year

Duration: 2 years

Research Authority due date: 8.6.23